NDC11 66215040201
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 66215-0402-01 | 66215-0402 |
| 66215-0402-1 | 66215-0402 |
| 66215-402-01 | 66215-402 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Veletri | EPOPROSTENOL | Actelion Pharmaceuticals US, Inc. | df502787-46ec-4dd1-a2c0-be90f6d95a5d | 2022-11-28 | Warnings, Adverse reactions | 66215-402-01 66215-402 66215040201 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.